Dr. Alexander M. Lesokhin, MD

  • New York, NY
  • Hematologist and oncologist
NPI1790950863PAC ID7416018528
Medicare services, 2024
900
Medicare patients, 2024
241
Part D claims, 2024
1,079
Publications
143
Clinical trials
9
Practice address
1275 York Avenue, New York, NY 10065
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Memorial Sloan Kettering Cancer Center

Hospital · New York, New York

See all 4 affiliations

Find Dr. Lesokhin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Alexander M. Lesokhin is a hematologist and oncologist in New York, New York

Dr. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Lesokhin's NPI, 1790950863, was assigned on April 29, 2008. Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002. Dr. Lesokhin holds New York license 231760.

NPI and contact details
Medicare PAC ID
7416018528
NPI enumeration date
April 29, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Alexander M. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York

Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Source: Dmand AI Affiliation Data

Dr. Alexander M. Lesokhin is affiliated with 1 site of care and 3 medical groups

Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Hematology Lymphoma Group. Dmand AI also links Dr. Lesokhin to 2 more medical groups, each named with a free account.

See all 4 affiliations for Dr. Lesokhin

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Alexander M. Lesokhin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lesokhin practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Memorial Sloan Kettering Cancer CenterAvailable with a free account
+2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lesokhin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Alexander M. Lesokhin is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Lesokhin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lesokhin is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Lesokhin's licenses on file in 4 states: New York, Florida, New Jersey and North Carolina.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 231760 · 2004 to 2027 · taxonomy 207RH0003X
  • Florida licenseSince 2021
  • New Jersey license2020 to 2027
  • North Carolina license2020 to 2022

Clinical focus

Dmand AI lists breast cancer, chronic leukemia, multiple myeloma and prostate cancer among the conditions Dr. Lesokhin treats.

Hematologists and oncologists near Dr. Lesokhin

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Alexander M. Lesokhin billed Medicare for 900 services in 2024

CMS data shows 900 Medicare services from Dr. Lesokhin across 7 procedure codes in 2024, for 241 Medicare patients. Medicare paid $87,362 for them.

Medicare services, 2024900
Medicare patients241
Paid by Medicare$87,362
Procedure codes7

Dr. Lesokhin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6552024: 82125%
Other services
2023: 02024: 79

Where Dr. Lesokhin's Medicare services took place, 2024

  • In an office74182%
  • In a facility15918%

Dr. Lesokhin compared with the New York median for hematologists and oncologists, 2024

  • Dr. Lesokhin
  • New York median
Medicare services
900vs 66835% above
Medicare patients
241vs 21015% above
Part D claims
922vs 2583.6 times

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Lesokhin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lesokhin

Need commercial claims for Dr. Lesokhin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lesokhin and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Alexander M. Lesokhin treated 241 Medicare patients in 2024, average age 75

CMS counts 241 Medicare patients who saw Dr. Lesokhin in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lesokhin's median patient age at 73, with 44% women.

Medicare patients, 2024241
Average age75
Average risk score2.79
Also on Medicaid18%

Dr. Lesokhin's Medicare patients by age, 2024

Dr. Lesokhin's Medicare patients by sex, 2024

  • Women10945%
  • Men13255%

Chronic conditions among Dr. Lesokhin's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol73%
  3. Arthritis55%
  4. Ischemic heart disease40%
  5. Chronic kidney disease36%
  6. Mood disorders32%
  7. Anxiety31%
  8. Diabetes31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lesokhin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Alexander M. Lesokhin wrote 1,079 Medicare Part D claims in 2024

In 2024, Dr. Lesokhin wrote 1,079 Medicare Part D claims for 154 patients. 80% of them were for generic drugs. CMS names the drug for 922 of them, across 25 drugs with 11 or more claims each, at $3,307,393 in total drug cost. In 2023, CMS named 646 claims across 21 drugs.

Part D claims, 20241,079
Drugs named by CMS25
Total drug cost$3.3M
Part D patients154

Dr. Lesokhin's Part D claims by kind of drug, 2024

  • Generic864 claims80%
  • Brand-name and other215 claims20%

Dr. Lesokhin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lesokhin's Part D claims, 2024

  • Opioids7%75 of 1,079 claims
  • Antibiotics8%89 of 1,079 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 6462024: 92243%

Drugs named by CMS: 25 in 2024, 21 in 2023.

See all prescribing by Dr. Lesokhin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Alexander M. Lesokhin scored 83 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lesokhin for performance year 2024, reported as part of a group. Dr. Lesokhin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lesokhin as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lesokhin's MIPS scores, performance year 2024

  • 83of 100Final score
  • 80.3of 100Quality
  • 40of 100Improvement Activities
  • 62of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lesokhin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Alexander M. Lesokhin has 143 publications on record

Dmand AI links 143 papers to Dr. Lesokhin, published from 2009 to 2025. 2016 was the busiest year, with 18. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal. Dr. Lesokhin has published most often in Blood. Dr. Lesokhin's most frequent co-authors are Hani Hassoun, MD, Sergio A. Giralt, MD and Sham Mailankody, MBBS.

Papers143
Years published2009 to 2025

Dr. Lesokhin's papers by year, 2016 to 2025

Topics Dr. Lesokhin writes about most

  • Multiple Myeloma
  • Antineoplastic Combined Chemotherapy Protocols
  • Antibodies, Monoclonal
  • Lenalidomide
  • Dexamethasone
  • Hematopoietic Stem Cell Transplantation
  • Antibodies, Monoclonal, Humanized
  • Immunotherapy, Adoptive

Dr. Lesokhin's most frequent co-authors

Recent publications by Dr. Lesokhin

See all 143 publications and co-authors

See who Dr. Lesokhin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lesokhin works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Alexander M. Lesokhin has worked on 9 clinical trials

Dmand AI links Dr. Lesokhin to 9 clinical trials, 4 of them phase 1 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Diabetes Mellitus, Insulin-Dependent, 12. Memorial Sloan Kettering Cancer Center sponsors the most, 4. Open Payments lists research payments to Dr. Lesokhin that name 2 trials.

Clinical trials with Dr. Lesokhin by phase

  1. 4Phase 1: 4 trials
  2. 2Phase 2: 2 trials
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Lesokhin's trials

  • Multiple Myeloma
  • Blood Protein Disorders
  • Diabetes Mellitus, Insulin-Dependent, 12
  • Diarrhea
  • Lymphoma

Investigators on the most trials with Dr. Lesokhin

Recent clinical trials with Dr. Lesokhin

See all 9 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Alexander M. Lesokhin received $94,592 in industry payments from 2016 to 2025

CMS Open Payments shows 135 general payments to Dr. Lesokhin from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Pfizer Inc. paid the most, $39,519. It also lists 80 research payments totaling $391,870 from 2016 to 2025, naming 2 clinical trials.

General payments to Dr. Lesokhin by program year, 2016 to 2025

General payments to Dr. Lesokhin by kind, 2016 to 2025

$94.6Kin total
  • Consulting fees$66,13670%
  • Speaker and faculty fees$9,39010%
  • Travel and lodging$8,1839%
  • Honoraria$7,9508%
  • Other$2,9333%

Companies that paid Dr. Lesokhin the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lesokhin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Alexander M. Lesokhin graduated from Albert Einstein College of Medicine

Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002.

  1. Medical schoolAlbert Einstein College of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Alexander M. Lesokhin accepts plans from 13 insurance carriers

Dr. Lesokhin is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • MVP Health Care
  • Regence Health Plans
  • +5 more carriersWith a free account

Plan types Dr. Lesokhin accepts, by number of carriers

  1. PPO9
  2. Medicare8
  3. POS5
  4. EPO4
  5. HMO4
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Alexander M. Lesokhin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Alexander M. Lesokhin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Alexander M. Lesokhin's NPI number?

Dr. Alexander M. Lesokhin's NPI number is 1790950863. It was assigned on April 29, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Alexander M. Lesokhin?

Dr. Alexander M. Lesokhin is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Alexander M. Lesokhin practice?

Dr. Lesokhin practices at 1275 York Avenue, New York, NY 10065. Dr. Lesokhin's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Lesokhin to 2 medical groups.

What is Dr. Alexander M. Lesokhin's medical license number?

Dr. Lesokhin holds New York license 231760, one of the licenses on file in 4 states.

Which states has Dr. Alexander M. Lesokhin been licensed in?

Dmand AI has state licenses on file for Dr. Lesokhin in New York (2004 to 2027), Florida (since 2021), New Jersey (2020 to 2027) and North Carolina (2020 to 2022).

Which hospitals is Dr. Alexander M. Lesokhin affiliated with?

Dr. Lesokhin practices at Memorial Sloan Kettering Cancer Center in New York, New York.

What medical group is Dr. Alexander M. Lesokhin part of?

Dr. Lesokhin is linked to Memorial Hematology Lymphoma Group. Dmand AI links Dr. Lesokhin to 2 more medical groups.

Does Dr. Alexander M. Lesokhin accept Medicare?

Yes. CMS data shows Dr. Lesokhin billed Medicare for 900 services in 2024, and Dr. Lesokhin accepts Medicare assignment.

Does Dr. Alexander M. Lesokhin offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lesokhin as offering telehealth services.

What is Dr. Alexander M. Lesokhin's MIPS score?

Dr. Lesokhin's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Alexander M. Lesokhin see?

CMS counts 241 Medicare patients who saw Dr. Lesokhin in 2024, with an average age of 75.

Is Dr. Alexander M. Lesokhin board certified?

Yes. Dr. Lesokhin is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Alexander M. Lesokhin bill to Medicare?

In 2024, Dr. Lesokhin's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).

Where did Dr. Alexander M. Lesokhin go to medical school?

Dr. Lesokhin graduated from Albert Einstein College of Medicine in 2002.

What drugs does Dr. Alexander M. Lesokhin prescribe most?

In 2024 Medicare Part D data, Dr. Lesokhin's most prescribed drugs by claims were Acyclovir, Lenalidomide and Omeprazole.

Has Dr. Alexander M. Lesokhin received payments from drug or device companies?

CMS Open Payments shows $94,592 in general payments to Dr. Lesokhin from 13 companies from 2016 to 2025. The largest total came from Pfizer Inc.

How long has Dr. Alexander M. Lesokhin been practicing?

Dr. Lesokhin graduated from medical school in 2002, 24 years ago.

Does Dr. Alexander M. Lesokhin do research?

Dmand AI links 143 publications to Dr. Lesokhin, published from 2009 to 2025. Dr. Lesokhin has worked on 9 clinical trials.

Who does Dr. Alexander M. Lesokhin publish with?

Dr. Lesokhin's most frequent co-authors are Hani Hassoun, MD (57 shared papers), Sergio A. Giralt, MD (50 shared papers) and Sham Mailankody, MBBS (42 shared papers).

What insurance does Dr. Alexander M. Lesokhin accept?

Dr. Lesokhin is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)